FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.55 Cr | ₹4.48 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹6.55 Cr |
| Mar2025 | ₹4.48 Cr |
How is Deferred Tax Assets / Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6.55 Cr | 46.03 | |
| Mar2025 | ₹4.48 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,420.0 Cr | -1.3% | 8.3% | 206.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -1.3% |
8.3% |
206.4% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses